TARGET-IBD: A 5-year longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)

Go Back to All Clinical Trials

TARGET-IBD: A 5-year longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)

Brief description of study

This study is looking to enroll patients with inflammatory bowel disease (IBD), which may include Crohn's disease (CD), ulcerative colitis (UC) and Indeterminate Colitis (IBDU), chronic inflammatory disorders of the gastrointestinal (GI) tract. The goals of this study are to collect information on patients with IBD to determine the natural course of the disease and to determine how procedures or treatments that may be recommended by doctors may affect IBD and general health. Researchers are interested in observing how these treatments, lifestyle changes and couseling work in patients who are treated by their doctors in routine practice. Information about which treatments are being used and response to these treatments will be collected to help researchers better understand how IBD is managed.

Clinical Study Identifier: s18-00055

Principal Investigator: David P Hudesman.

Other Investigator: Shannon Chang.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies